5:33 PM
 | 
Dec 21, 2012
 |  BC Extra  |  Company News

Cangene gains on vaccine approval

Cangene Corp. (TSX:CNJ) gained C$0.26 (17%) to C$1.78 on Friday after FDA approved the company's Varizig to reduce the severity of Varicella...

Read the full 100 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >